← Leaderboards
Stefanie Sarantopoulos
Univ Of North Carolina Chapel Hill
$7,871,947
Attributed
$7,871,947
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,871,947 · 4
By mechanism
R01$6,866,391 · 1
K08$520,352 · 1
R21$415,257 · 1
P30$69,947 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Thomas L Kash$22,512,546
- James E Bear$10,095,665
Others in their field
Top investigators on “Hematopoietic Stem Cell Transplantation”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$75,325,770
- Bruce R. Blazar · University Of Minnesota$31,634,829
- Marcel R M Van Den Brink · Sloan-Kettering Institute For Cancer Res$31,596,251
- Leslie S Kean · Emory University$28,926,612
- Effie W Petersdorf · Fred Hutchinson Cancer Research Center$28,889,276
Research focus
Hematopoietic Stem Cell TransplantationImmuneB-Lymphocyte SubsetsAntibodiesReceptorResponseChronic Graft Versus Host DiseaseSignal TransductionAllogenicB-LymphocytesCancer PatientProductionResearch PersonnelBone MarrowLifeHematological DiseaseReceptor SignalingAutoimmune DiseasesPathologicMorbidity - Disease RateAmericanBloodPathologyPathway Interactions
Grant awards (16)
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$731,706
R01 · FY2025 · HL · contact PI
Harnessing B Cells after Stem Cell Transplant to Produce Novel CAR-Ts$415,257
R21 · FY2025 · CA · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$717,072
R01 · FY2024 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$731,706
R01 · FY2023 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$731,706
R01 · FY2022 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$736,536
R01 · FY2021 · HL · contact PI
Immuno-Oncology Program$69,947
P30 · FY2021 · CA · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$642,579
R01 · FY2019 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$642,579
R01 · FY2018 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$642,579
R01 · FY2017 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$642,579
R01 · FY2016 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$647,349
R01 · FY2015 · HL · contact PI
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease$127,683
K08 · FY2014 · HL · contact PI
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease$127,683
K08 · FY2013 · HL · contact PI
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease$132,493
K08 · FY2012 · HL · contact PI
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease$132,493
K08 · FY2011 · HL · contact PI